000 01702nam a2200349 a 4500
001 ebr10677831
003 CaPaEBR
006 m u
007 cr cn|||||||||
008 130403s2013 gw a sb 001 0 eng d
020 _z9783527332557
020 _z9783527670390 (e-book)
040 _aCaPaEBR
_cCaPaEBR
035 _a(OCoLC)841170430
050 1 4 _aRC119
_b.T79 2013eb
245 0 0 _aTrypanosomatid diseases
_h[electronic resource] :
_bmolecular routes to drug discovery /
_cedited by Timo J�ager, Oliver Koch, and Leopold Floh�e.
260 _aWeinheim :
_bWiley-VCH,
_c2013.
300 _axxviii, 547 p. :
_bill. (some col.).
490 1 _aDrug discovery in infectious diseases ;
_vv. 4
504 _aIncludes bibliographical references and index.
505 0 _apt. 1. Disease burden, current treatments, medical needs, and strategic approaches -- pt. 2. Metabolic peculiarities in the trypanosomatid family guiding drug discovery -- pt. 3. Validation and selection of drug targets in kinetoplasts -- pt. 4. Examples of target-based approaches and compounds under consideration.
533 _aElectronic reproduction.
_bPalo Alto, Calif. :
_cebrary,
_d2013.
_nAvailable via World Wide Web.
_nAccess may be limited to ebrary affiliated libraries.
650 0 _aParasitic diseases.
650 0 _aTrypanosomatidae.
655 7 _aElectronic books.
_2local
700 1 _aJ�ager, Timo.
700 1 _aKoch, Oliver.
700 1 _aFloh�e, Leopold.
710 2 _aebrary, Inc.
830 0 _aDrug discovery in infectious diseases ;
_vv. 4.
856 4 0 _uhttp://site.ebrary.com/lib/rucke/Doc?id=10677831
_zAn electronic book accessible through the World Wide Web; click to view
999 _c59332
_d59332